AKIRIN2 and liver cancer: Silencing FBI1/Akirin2 expression leads to increased Lu/BCAM expression, while the overexpression of Lu/BCAM inhibits crucial biological behaviors, such as clone formation, cell migration and invasion in rat liver cancer cells [44].